ASPIVIX SA
Modern Gynecological Products for Women's Health
ASPIVIX is revolutionizing gynecology with a next-generation, suction-based cervical device that replaces the 100-year-old tenaculum—a painful, traumatic tool still used in over 100M procedures annually. Our device offers equivalent maneuverability without bleeding, pain, or tissue tear, dramatically improving patient experience. By making IUD insertion gentler and more acceptable, ASPIVIX empowers broader adoption of the most effective reversible contraceptive, addressing one of the world’s most pressing public health challenges: unplanned pregnancies.
Only registered users have access to funding information.
Please log in or register to continue. Registration is free.
12.02.2026
From trials to market: medtechs advance clinical programs (startupticker.ch)
24.11.2025
Swiss startups across industries in the global spotlight (startupticker.ch)
21.10.2025
Breakthrough US Launch and Validation for Aspivix (startupticker.ch)
11.11.2024
Strong startup delegation at Medica 2024 (startupticker.ch)
01.11.2024
Swiss ingenuity shines on TIME's Best Inventions 2024 list (startupticker.ch)
Last Tweets
No Jobs
Videos
Aspivix's story - short movie
Tenaculum vs. Carevix
Carevix - Modern Cervical Stabiliser for gynecology
Watch-out and learn more how Aspivix tackles the pain and contribute reducing unintended pregancies!
TOP 100 Swiss Startup Award
The TOP 100 Swiss Startup Ranking features the 100 most promising startups that are not older than five years and are selected by a jury of early-stage investors.
Venture Kick
Venture Kick supports potential entrepreneurs with start capital up to CHF 150'000 as well as hands-on execution support and access to a nationwide network of investors and experts in the startup field. Multiple times per year, 8 selected projects get the opportunity to present their business ideas in front of a panel. The 5 most promising projects enter the support process. After 9 months at the latest, the startups incorporate and enter the market. Since 2007, Venture Kick has invested over CHF 58 million in over 1111 projects.
Venture Leaders Life Sciences
The venture leaders - the members of the Swiss national startup team- have a clear-cut goal. They envision themselves as global players and want to take the first step to their global expansion. The ten-day business development program is specifically structured to help them achieve this goal.
ASPIVIX SA
Modern Gynecological Products for Women's Health
Website:
www.aspivix.com
Headquarter:
Epalinges
Foundation Date:
July 2015
Technology:
- Medtech
Sectors:
- Mechanics
- Micro technologies
- Medical devices
- Medtech
- Surgery
- Urology
Support received
